No Data
No Data
Devonian Health Group to Participate in Renmark's Chicago Virtual Non-Deal Roadshow Series on Wednesday, July 17, 2024
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), announced today that they will be participating in Renmark Financial Communications
Devonian Health Group to Participate in Renmark's Los Angeles Virtual Non-Deal Roadshow Series on Wednesday, July 10, 2024
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), announced today that they will be participating in Renmark Financial Communications In
Devonian Health Group to Participate in Renmark's Boston Virtual Non-Deal Roadshow Series on Wednesday, June 26, 2024
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), announced today that they will be participating in Renmark Financial Communications In
Devonian Health Group Founder Assumes Chair, COO Roles
Devonian Health Group (GSD.V) on Monday named Andre Boulet the new chair of the company's board and chief operating officer. Boulet is the founder of the clinical-stage botanical pharmaceutical compan
Devonian Health Group Reports Second Quarter 2024 Financial Results and Business Update
Devonian Health Group Closes Non-Brokered Private Placement; Down Nearly 7%
Devonian Health Group Inc. (GSD.V) said Thursday that it has raised gross proceeds of $223,800 by completing its non-brokered private placement. The company's stock dropped 6.8% on last look on Thursd